Karbe Eberhard, Kerlin Roy L
Toxicol Pathol. 2002 Mar-Apr;30(2):216-27. doi: 10.1080/019262302753559551.
Cystic degeneration/spongiosis hepatis in rats has been proposed to be a preneoplastic and/or neoplastic lesion by some authors, because of its proliferative properties and persistent increased cell turnover rate in stop experiments using hepatocarcinogens, and the assumption that it can develop into a sarcoma. The neoplastic potential of cystic degeneration is questioned in this review article. Cystic degeneration, which appears to derive from altered Ito cells, does not have neoplastic histomorphologic characteristics, although it may be composed of cells with an increased mitotic index. In this regard, persistent proliferation is also seen with other nonneoplastic lesions. Arguments are presented to show that the induced, probably extremely rare sarcoma that was associated with cystic degeneration most likely derives from the very rare induced spherical Ito-cell aggregate with an unusually high cellular turnover rate in rats treated with hepatocarcinogens, and not from cystic degeneration. Also, in none of 12 referenced standard oncogenicity studies with chemically induced cystic degeneration was the lesion associated with mesenchymal (Ito-cell) tumors. Consequently, evidence is lacking that cystic degeneration in rats should be classified as a preneoplastic or neoplastic lesion. The 12 oncogenicity studies in rats with induced cystic degeneration showed a marked sex predilection, with males more likely to develop either spontaneous or chemically induced lesions. In these 12 studies, cystic degeneration was more often associated with hepatocellular hypertrophy or hepatotoxicity. rather than hepatocarcinogenicity. Thus, it is concluded that hepatocarcinogens induce cystic degeneration, not because they are carcinogenic. but because they have other effects on the liver, and that cystic degeneration may be a secondary/reparative change. Cystic degeneration in fish parallels the situation in rats in many respects, yet the existence of the lesion in other species, including man, is not as well supported. Based on the data presented in this review, spontaneous and induced cystic degeneration in rats and fish is not a preneoplastic or neoplastic lesion and risk assessment for man can be based on no-effect levels and safety margins, as for other nonneoplastic adverse effects that have no counterpart in man.
一些作者认为大鼠的肝囊肿性变性/海绵样变是一种癌前和/或肿瘤性病变,因为其具有增殖特性,并且在使用肝癌致癌物的终止实验中细胞更新率持续增加,同时还基于它可发展为肉瘤的假设。在这篇综述文章中,肝囊肿性变性的肿瘤形成潜能受到质疑。肝囊肿性变性似乎源自改变的贮脂细胞,尽管它可能由有丝分裂指数增加的细胞组成,但并不具备肿瘤组织形态学特征。在这方面,其他非肿瘤性病变也可见持续增殖。有观点表明,与肝囊肿性变性相关的诱导性肉瘤(可能极其罕见)极有可能源自用肝癌致癌物处理的大鼠中非常罕见的诱导性球形贮脂细胞聚集体,其细胞更新率异常高,而非源自肝囊肿性变性。此外,在12项引用的关于化学诱导肝囊肿性变性的标准致癌性研究中,均未发现该病变与间叶性(贮脂细胞)肿瘤相关。因此,缺乏证据表明大鼠的肝囊肿性变性应归类为癌前或肿瘤性病变。12项关于大鼠诱导性肝囊肿性变性的致癌性研究显示出明显的性别偏好,雄性更易发生自发性或化学诱导性病变。在这12项研究中,肝囊肿性变性更常与肝细胞肥大或肝毒性相关,而非与肝癌致癌性相关。因此,得出的结论是,肝癌致癌物诱导肝囊肿性变性,并非因为它们具有致癌性,而是因为它们对肝脏有其他影响,并且肝囊肿性变性可能是一种继发性/修复性改变。鱼类的肝囊肿性变性在许多方面与大鼠的情况相似,但在包括人类在内的其他物种中,该病变的存在证据不足。基于本综述中呈现的数据,大鼠和鱼类的自发性和诱导性肝囊肿性变性并非癌前或肿瘤性病变,对人类的风险评估可基于无作用水平和安全限度,如同对人类无对应情况的其他非肿瘤性不良反应一样。